Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Athletes with Premature Ventricular Beats

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Jan 21

PMID 35054118

Authors

Giulia Brunetti

Alberto Cipriani

Martina Perazzolo Marra

Manuel De Lazzari

Barbara Bauce

Chiara Calore

Ilaria Rigato

Francesca Graziano

Riccardo Vio

Domenico Corrado

Alessandro Zorzi

Affiliations

Soon will be listed here.

Abstract

Premature ventricular beats (PVBs) in athletes are not rare. The risk of PVBs depends on the presence of an underlying pathological myocardial substrate predisposing the subject to sudden cardiac death. The standard diagnostic work-up of athletes with PVBs includes an examination of family and personal history, resting electrocardiogram (ECG), 24 h ambulatory ECG (possibly with a 12-lead configuration and including a training session), maximal exercise testing and echocardiography. Despite its fundamental role in the diagnostic assessment of athletes with PVBs, echocardiography has very limited sensitivity in detecting the presence of non-ischemic left ventricular scars, which can be revealed only through more in-depth studies, particularly with the use of contrast-enhanced cardiac magnetic resonance (CMR) imaging. The morphology, complexity and exercise inducibility of PVBs can help estimate the probability of an underlying heart disease. Based on these features, CMR imaging may be indicated even when echocardiography is normal. This review focuses on interpreting PVBs, and on the indication and role of CMR imaging in the diagnostic evaluation of athletes, with a special focus on non-ischemic left ventricular scars that are an emerging substrate of cardiac arrest during sport.

Citing Articles

The Role of Nuclear Medicine in the Diagnostic Work-Up of Athletes: An Essential Guide for the Sports Cardiologist.

Zorzi A, Bondarev S, Graziano F, Cecere A, Giordani A, Turk L J Cardiovasc Dev Dis. 2024; 11(10).

PMID: 39452277 PMC: 11508806. DOI: 10.3390/jcdd11100306.

Lightweight preprocessing and template matching facilitate streamlined ischemic myocardial scar classification.

Udin M, Armstrong S, Kai A, Doyle S, Ionita C, Pokharel S J Med Imaging (Bellingham). 2024; 11(2):024503.

PMID: 38525295 PMC: 10956816. DOI: 10.1117/1.JMI.11.2.024503.

Ventricular arrhythmias recorded on 12-lead ambulatory electrocardiogram monitoring in healthy volunteer athletes and controls: what is common and what is not.

Graziano F, Mastella G, Merkely B, Vago H, Corrado D, Zorzi A Europace. 2023; 25(9).

PMID: 37589170 PMC: 10469403. DOI: 10.1093/europace/euad255.

Evolving spectrum of arrhythmogenic cardiomyopathy: Implications for Sports Cardiology.

Graziano F, Cipriani A, Balla D, Bondarev S, Perazzolo Marra M, Bauce B Clin Cardiol. 2023; 46(9):1072-1081.

PMID: 37357443 PMC: 10540004. DOI: 10.1002/clc.24069.

Multimodality Cardiac Imaging in Young and Veteran Athletes: Updates on Atrial Function Assessment, Arrhythmia Predisposition and Pathology Discrimination.

Androulakis E, Perone F J Clin Med. 2023; 12(3).

PMID: 36769443 PMC: 9917427. DOI: 10.3390/jcm12030797.

References

Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Brusin M . Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol. 2001; 38(2):364-70. DOI: 10.1016/s0735-1097(01)01403-6. View

Sharma S, Merghani A, Mont L . Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015; 36(23):1445-53. DOI: 10.1093/eurheartj/ehv090. View

Lie O, Klaboe L, Dejgaard L, Skjolsvik E, Grimsmo J, Bosse G . Cardiac Phenotypes and Markers of Adverse Outcome in Elite Athletes With Ventricular Arrhythmias. JACC Cardiovasc Imaging. 2020; 14(1):148-158. DOI: 10.1016/j.jcmg.2020.07.039. View

Sharma S, Drezner J, Baggish A, Papadakis M, Wilson M, Prutkin J . International recommendations for electrocardiographic interpretation in athletes. Eur Heart J. 2017; 39(16):1466-1480. DOI: 10.1093/eurheartj/ehw631. View

De Lazzari M, Zorzi A, Cipriani A, Susana A, Mastella G, Rizzo A . Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy. J Am Heart Assoc. 2018; 7(22):e009855. PMC: 6404435. DOI: 10.1161/JAHA.118.009855. View

Negri F, Muser D, Driussi M, Sanna G, Mase M, Cittar M . Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study. Int J Cardiol. 2021; 345:61-67. DOI: 10.1016/j.ijcard.2021.10.148. View

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

Hundley W, Bluemke D, Finn J, Flamm S, Fogel M, Friedrich M . ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010; 55(23):2614-62. PMC: 3042771. DOI: 10.1016/j.jacc.2009.11.011. View

Gagliardi M, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C . Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol. 1991; 68(10):1089-91. DOI: 10.1016/0002-9149(91)90501-b. View

10.

Tower-Rader A, Mohananey D, To A, Lever H, Popovic Z, Desai M . Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature. JACC Cardiovasc Imaging. 2018; 12(10):1930-1942. DOI: 10.1016/j.jcmg.2018.07.016. View

11.

Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E . Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2007; 35(5):933-41. DOI: 10.1007/s00259-007-0650-8. View

12.

Cipriani A, Zorzi A, Sarto P, Donini M, Rigato I, Bariani R . Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance. Heart Rhythm. 2018; 16(2):239-248. DOI: 10.1016/j.hrthm.2018.08.029. View

13.

Grigoratos C, Pantano A, Meschisi M, Gaeta R, Ait-Ali L, Barison A . Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts. Int J Cardiovasc Imaging. 2020; 36(5):913-920. DOI: 10.1007/s10554-020-01783-y. View

14.

Van Camp S, Bloor C, Mueller F, Cantu R, Olson H . Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995; 27(5):641-7. View

15.

Fischer K, Obrist S, Erne S, Stark A, Marggraf M, Kaneko K . Feature Tracking Myocardial Strain Incrementally Improves Prognostication in Myocarditis Beyond Traditional CMR Imaging Features. JACC Cardiovasc Imaging. 2020; 13(9):1891-1901. DOI: 10.1016/j.jcmg.2020.04.025. View

16.

Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, De Lazzari M . Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020; 319:106-114. DOI: 10.1016/j.ijcard.2020.06.005. View

17.

Corrado D, van Tintelen P, McKenna W, Hauer R, Anastastakis A, Asimaki A . Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2019; 41(14):1414-1429. PMC: 7138528. DOI: 10.1093/eurheartj/ehz669. View

18.

Di Gioia C, Giordano C, Cerbelli B, Pisano A, Perli E, Dominicis E . Nonischemic left ventricular scar and cardiac sudden death in the young. Hum Pathol. 2016; 58:78-89. DOI: 10.1016/j.humpath.2016.08.004. View

19.

Heidbuchel H . The athlete's heart is a proarrhythmic heart, and what that means for clinical decision making. Europace. 2017; 20(9):1401-1411. DOI: 10.1093/europace/eux294. View

20.

Maron B, Udelson J, Bonow R, Nishimura R, Ackerman M, Estes 3rd N . Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A.... J Am Coll Cardiol. 2015; 66(21):2362-2371. DOI: 10.1016/j.jacc.2015.09.035. View